Latest Asx News

NT Minerals Limited reported a net cash outflow of A$590,000 for Q3 2025 but bolstered its liquidity with A$1.07 million from investing activities, leaving it with over two quarters of funding runway.

Pacific Smiles Group Limited shares will be suspended from ASX trading following compulsory acquisition notices issued by Beam Dental Bidco Pty Ltd, signaling a significant ownership change.

Strike Resources advances its high-grade Apurímac Iron Ore Project amid political upheaval in Peru, while its Lithium Energy stake pushes forward with key acquisitions and exploration despite ASX suspension.

TasFoods reports a 13.2% revenue decline in Q3 2025 driven by oversupply and discounting in the Tasmanian poultry market, while advancing a $2 million sale of Pyengana Dairy and reducing debt through property sales.

Resources & Energy Group Limited (REZ) has secured approval to expand gold vat leach production at its East Menzies Gold Project, transitioning from trial to commercial scale. The company also announced a maiden JORC 2012 Inferred Mineral Resource at Gigante Grande, underpinning future growth.

Tinybeans Group Limited reports steady subscription revenue and improved cash flow in Q1 FY26, while launching a new iOS Photo Store to diversify income streams and enhance user monetisation.

Chariot Corporation has secured a controlling stake in a major Nigerian lithium portfolio, marking a strategic entry into the Africa-China lithium corridor, supported by a A$1.6 million capital raise and enhanced working capital facility.

OzAurum Resources reports strong drilling results at its Mulgabbie North Gold Project and regains full control of its Feasibility Study, positioning the company for accelerated development amid record gold prices.

Evolution Energy Minerals has successfully raised A$1.75 million through a fully underwritten rights issue, accelerating its Chilalo Graphite Project timeline to first ore production by October 2027. The company is also advancing exploration at its Chikundo copper project while streamlining operations.

Tryptamine Therapeutics has initiated the world’s first clinical trial of its IV-infused psilocin drug, TRP-8803, targeting Binge Eating Disorder, alongside a pioneering EEG biomarker collaboration and new funding.

Alice Queen Limited has reported significant progress at its Viani Fiji Project, extending high-grade gold mineralisation over a 5km strike. The company also registered a mining lease application for its Horn Island Project and raised $1 million via convertible notes to fund ongoing exploration.

Manhattan Corporation has reported promising high-grade gold and polymetallic assay results from its Hook Lake Project in Nunavut, Canada, alongside a $2.2 million capital raise to fund upcoming exploration activities.